Work

Supplementary Table 1 from Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas

Year: 2025

Type: supplementary-materials

Abstract: Supp Table ST1 shows doses of PRIT reagents

DOI: 10.1158/1535-7163.30761665

Authors: Johnnie J. Orozco, Manuela C. Matesan, Sally J. Lundberg, Robyn L. Haaf, Robert S. Miyaoka, Darrell R. Fisher, Ted A. Gooley, Damian J. Green, Brenda M. Sandmaier, Paul S. Martin, Ajay K. Gopal

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4416903070

Cites:

Cited by:

Related to: